We need your help now
Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
Sign in. It’s quick, free and it’s up to you.
An account is an optional way to support the work we do. Find out more.
By continuing, you are indicating that you accept our Terms of Service and Privacy Policy.
ASTRAZENECA HAS ANNOUNCED plans to build an advanced manufacturing facility in Blanchardstown, Dublin, creating up to 100 jobs.
At a cost of €306 million ($360 million), the biopharmaceutical company behind the Covid-19 vaccine will establish a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules at the Alexion Campus in College Park.
The British-Swedish pharmaceutical outfit said the new plant will “transform the development and commercialisation of new medicines” and create about 100 highly skilled jobs in science and engineering.
“In choosing Ireland as the location for its new next-generation active pharmaceutical ingredient manufacturing facility, AstraZeneca joins the very strong and successful network of global life sciences companies we have in Ireland. I wish them every success with their operations here,” Taoiseach Micheál Martin said.
Great news that @AstraZeneca is to establish its first ever manufacturing facility in Ireland, creating 100 highly-skilled jobs.
— Micheál Martin (@MichealMartinTD) September 21, 2021
The $360m investment in Dublin is a huge boost to the area, and to the entire country’s life-sciences sector.@IDAIRELAND
AstraZeneca CEO Pascal Soriot said he was “tremendously proud”, adding that the investment will “nurture the country’s dynamic life sciences sector and allow for the development of high value-added medicines”.
AstraZeneca said the new plant will significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes. It said the design of the plant will permit the addition of the capability to manufacture a wide range of medicines, including new modalities such as antibody-drug conjugates and oligonucleotides.
Pam Cheng, executive vice president, explained: “The future manufacturing of APIs for our medicines includes compounds with highly complex synthesis, requiring next generation technologies and capabilities that can respond quickly and nimbly to rapidly-changing clinical and commercial needs.”
To embed this post, copy the code below on your site
Great little vaccine. Roll on the 3rd and 4th boosters.
@Paul Whitehead: shows what you know. Snide remark to be edgy. Booster won’t be from them as the booster will be mRNA. Bet as edgy as you are you still comply and wear masks
@Tom Ripley: Why has the Journel not banned you when Twitter has.
@Darren Norris: “banned” have you got a problem with free speech or is it only people that don’t agree with your world view than you want banned.
@Denis Ryan: hey Twitter, you missed this looney. Ban him too
@Johnny: I’m the looney? Nice profile pic, don’t worry someday you will find a partner and you won’t have to watch Jonny Sins as much.
@Paul Whitehead: what in the conspiracy thread have I stumbled into here.
Why not build it in the Midlands no room in Dublin
@Marty Lawless: build it anywhere other than Dublin say Wexford for example major port on the doorstep access to Europe close proximity to Dublin airport and other hubs. I know it’s down to the fact the skill set is in Dublin but if you build it elsewhere the skill set will follow and relieve the pressure off Dublin.
@Marty Lawless: apparently there is, it says it in the first three lines of the article. Did you not read it?
Talent pool not in Wexford currently for it….plus it’s adding tonan existing facility.
@: It’s being built 14km from Dublin Airport in an industrial area where they are literally surrounded by freight companies.
@Mr Snrub: but if a facility not just AstraZeneca built outside of Dublin the talent pool will follow for want of a better life outside Dublin
@Tommy Roche: we have lots of freight companies here in Wexford too Nolan Transport Perennial freight Baku Gls Roche freight plus many many more Rosslare on our doorstep also. More or less straight run to Dublin on M11 little or no congestion. My argument is that most other areas are largely overlooked in favor of Dublin which is busting at the seams.
Have to agree with you there. Sure Dubliners are moving out as it is.
Great news,however there’s 4 other cities outside Dublin crying for investment when you can’t possibly fit anymore into Dublin.FDI and the government need to start letting the other regional cities expand
@James: You do realise they’re a private company who can choose where they want to set up.
@Darren Byrne: you do realise that nearly half of irelands total GDP comes from Dublin alone leaving scraps off the table for waterford cork limerick and galway to fight it out.totally unsustainable and lob sided.its about time FDI got it’s act together and started steering companies into regional cities
Getting contracts in before that Corp tax hike
Any chance me hole would look after his own part of the country like the other lepers have done for generations? Skill set is now in limerick and huge skill set also in Cork. Being led by the nose by the capitals brigade as usual. Dublin is choc a bloc, huge rent costs, unaffordable to buy for most.
@AJ: your hole is probably the most intelligent part of you. So tell it to go ahead and check it out.
@Paul Furey: rents are also high outside of dublin…do you ever read other news?
@AJ: so Michael Martin is on the board of astra zeneca and can make these decisions… I never knew…
Oh boy, Alex Jones’ internet army won’t like this :)
@Joseph Bent: who?
@K C: Alex Jones’ internet army
@K C: the army that follows Alex Jones
@K C: The army on the internet belonging to Alex Jones
That’ll be a shot in the arm to the jobs market.
Just what the doctor ordered!
Faaaantastic!
Jaysus, is there nobody to object to it? WHERE IS PETER?
@John Mc Donagh: Don’t mind ‘where is Peter’.
Where is the fella in red and white tee shirt gone‽
The same company that screwed the eu on the vaccine deal while hiding stocks for shipping outside the bloc
Out the door with them
@James Grant: the EU messed that up too. The AZ is cheaper than the two mRNA and is the only one trying to fairly distribute its vaccine to poorer countries.
At least its not built to rent apartments on the land
@Ger McCarthy: or the lad from Leixlip in the wellingtons on the steps of the four goldmines.
AZ drugs only handle the small viruses maybe 90nm size, they need to improve their products to handle bigger ones cos they worse , obviously.
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say